Global Pharmaceuticals & Biotech Leverage Leaders

Sai Life Sciences

Market Cap: ₹250.6b

Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.

Alkem Laboratories

Market Cap: ₹633.9b

A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.

Tasly Pharmaceutical Group

Market Cap: CN¥21.2b

Engages in the research, development, production, and sale of pharmaceuticals in China.

Asymchem Laboratories (Tianjin)

Market Cap: CN¥39.9b

Asymchem Laboratories (Tianjin) Co., Ltd.

Jiangsu Hengrui PharmaceuticalsLtd

Market Cap: CN¥310.7b

A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.

Sun Pharmaceutical Industries

Market Cap: ₹4.3t

A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.

Aurobindo Pharma

Market Cap: ₹850.4b

A biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.

D&D Pharmatech

Market Cap: ₩4.1t

Engages in the research and development and manufacturing of pharmaceuticals in South Korea.

Otsuka Holdings

Market Cap: JP¥5.4t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥34.0b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

Imeik Technology DevelopmentLtd

Market Cap: CN¥27.9b

Engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China.

Biogen

Market Cap: US$28.7b

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.

Vaxcyte

Market Cap: US$6.6b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Stevanato Group

Market Cap: US$4.7b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

ACADIA Pharmaceuticals

Market Cap: US$3.6b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Dianthus Therapeutics

Market Cap: US$4.2b

A clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases.

SCHOTT Pharma KGaA

Market Cap: €2.6b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.

Exelixis

Market Cap: US$13.2b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Corcept Therapeutics

Market Cap: US$8.4b

A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Abbott India

Market Cap: ₹554.1b

Operates as a pharmaceutical company in India.

Peptron

Market Cap: ₩5.5t

Engages in the development of peptide-based medicines.

Sino Biopharmaceutical

Market Cap: HK$79.5b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

3SBio

Market Cap: HK$40.6b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

Rubicon Research

Market Cap: ₹211.8b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

Jiangsu Nhwa Pharmaceutical

Market Cap: CN¥19.3b

Engages in research, development, production, and sale of central nervous system products in China.

Cipla

Market Cap: ₹1.1t

Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.

Hanmi Pharm

Market Cap: ₩5.2t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

AstraZeneca Pharma India

Market Cap: ₹206.2b

A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.

Chugai Pharmaceutical

Market Cap: JP¥12.2t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Kiniksa Pharmaceuticals International

Market Cap: US$3.8b

A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.

IDEAYA Biosciences

Market Cap: US$2.4b

A precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.

Merck KGaA

Market Cap: €58.7b

Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.

Bachem Holding

Market Cap: CHF 5.0b

Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.

Krka d. d

Market Cap: €7.8b

A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

United Therapeutics

Market Cap: US$23.1b

Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Camurus

Market Cap: SEK 31.5b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.